The authors identified PET-based biomarkers that directly link hypoxia to the heterogeneous alternation of PD-L1 expression, highlighting the potential of imaging biomarkers to characterize hypoxia-induced physiological heterogeneity and support treatment planning in breast cancer. This evidence concerns the gene CD274 and breast carcinoma.